Economic evaluation of nimotuzumab for the first-line treatment of K-Ras wild-type advanced pancreatic cancer based on the partitioned survival model

HUANG Jinlong, YE Hanyun, LIN Jingyang, LUO Dan, ZHENG Xiaochun

Chinese Journal of Hospital Pharmacy ›› 2026, Vol. 46 ›› Issue (2) : 175-180.

PDF(1169 KB)
PDF(1169 KB)
Chinese Journal of Hospital Pharmacy ›› 2026, Vol. 46 ›› Issue (2) : 175-180. DOI: 10.13286/j.1001-5213.2026.02.08
Drug and Clinical Practice

Economic evaluation of nimotuzumab for the first-line treatment of K-Ras wild-type advanced pancreatic cancer based on the partitioned survival model

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2026, 46(2): 175-180 https://doi.org/10.13286/j.1001-5213.2026.02.08

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1169 KB)

Accesses

Citation

Detail

Sections
Recommended

/

〈 〉